The study investigates the role of metabolic rewiring in glioblastoma (GBM), particularly focusing on glioblastoma stem cells (GSCs). It highlights how GSCs utilize fatty acid oxidation (FAO) to enhance their tumorigenic capabilities and resist therapies. By analyzing samples from both recurrent and newly diagnosed GBM patients, researchers identified a distinct FAO-enriched profile in GSCs compared to non-malignant astrocytes.
In vivo experiments indicated that manipulating lipid availability in the brain—specifically through a low carbohydrate high fat diet (LCHFD)—can impact tumor formation by GSCs. Additionally, the study explored how LCHFD alters the gut microbiome and regulates circadian rhythms.
Ultimately, the findings suggest that targeting FAO in the postoperative phase before chemoradiation could serve as a non-drug strategy to delay GBM recurrence, proposing dietary modulation as a potential therapeutic avenue to enhance patient outcomes.
